VT S0300The bill proposes that hospitals must test for fentanyl when they conduct urine drug screenings. This aims to better identify patients who may be using fentanyl, a powerful and potentially dangerous opioid. The intention is to improve patient care and safety by recognizing fentanyl use more effectively.
VT S0300 is a senate bill in the Vermont 2025-2026 Session, sponsored by Terry Williams (R), currently “Introduced” since January 23, 2026.
We track 1,717 Vermont bills this session, 11 of them sponsored by Terry Williams.
Supporters of the bill argue that it is a crucial step in combating the opioid crisis by ensuring that fentanyl use is detected early in hospital settings. They believe that this measure could lead to more informed treatment decisions and ultimately save lives by addressing fentanyl use proactively.
Critics may argue that the bill could lead to unnecessary stigma against patients who are being tested for drug use. They might also raise concerns about the potential for increased healthcare costs and the implications of labeling patients based on drug screening results without considering the broader context of substance use.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Vermont General Assembly. Conflict-of-interest analysis for this bill is coming soon.
What does VT S0300 do?
The bill proposes that hospitals must test for fentanyl when they conduct urine drug screenings. This aims to better identify patients who may be using fentanyl, a powerful and potentially dangerous opioid. The intention is to improve patient care and safety by recognizing fentanyl use more effectively.
What is the status of VT S0300?
VT S0300 is currently “Introduced” in the Vermont legislature.
Who sponsored VT S0300?
Terry Williams (R) sponsored VT S0300.
